TREA

79409929 - EXOEDIT

Follow

Information

  • Trademark
  • 79409929
  • Serial Number
    79409929
  • Filing Date
    June 18, 2024
    7 months ago
  • Transaction Date
    February 09, 2025
    a day ago
  • Status Date
    January 22, 2025
    19 days ago
  • Status Code
    641
  • Current Location
    TMO LAW OFFICE 119
    Employee Name
    CORWIN, CHARLOTTE
  • Law Office Assigned Location Code
    N10
  • Owners
Information
Mark Drawing Code
4
Mark Identification
EXOEDIT
Case File Statements
  • GS0051: Pharmaceuticals; pharmaceutical preparations and substances; pharmaceutical preparations, namely, a drug delivery system comprising genetically engineered or purified exosomes for therapeutic use; pharmaceutical preparations, namely, exosomes to deliver protein or nucleic acids or viral vectors for therapy; medicine; medical preparations and articles; biological preparations for medical purposes; biological preparations for the treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint/ligament strain/tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism (IEMs), lysosomal storage disorders and urea cycle disorders; biological preparations comprising exosome; biological preparations comprising a therapeutic target protein-loaded, nucleic acid-loaded or virus-loaded exosome; biological preparations comprising exosome for medical use; biological reagents for medical use; mixed biological preparations for medical purposes; mixed biological preparations for the prevention and treatment of infectious diseases; extracellular vesicle-based nucleic acid preparations for therapeutical use for the prevention and treatment of infections or disease; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays for testing of exosomes for use in disease detection; diagnostic kits comprised of medical diagnostic reagents and assays that test for the presence of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint/ligament strain/tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism (IEMs), lysosomal storage disorders and urea cycle disorders; gene therapy products, namely, gene delivery pharmaceuticals; pharmaceutical preparations for gene therapy, gene editing, and genome editing; pharmaceutical preparations for use in gene therapies for the treatment of genetic diseases and disorders.
  • PM0001: EXO EDIT
  • GS0441: Medical services; medical and pharmaceutical consultancy; medical diagnostics; medical analysis and examinations; medical treatment services; medical screening; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of cancer, viral and bacterial based infections and diseases; medical monitoring, testing, inspection and analysis services relating to the diagnosis and treatment of cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint/ligament strain/tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism (IEMs), lysosomal storage disorders and urea cycle disorders; information, advisory and consultancy services relating to the aforesaid.
  • GS0421: Scientific, medical and pharmaceutical research and development services; pharmaceutical drug development services; research and development of pharmaceutical preparations; research and analysis services; biological research; clinical research; providing medical and scientific research information in the field of filtration of exosomes from cultured cells or blood; scientific investigations for medical purposes; scientific laboratory services; medical laboratory services; laboratory research services relating to pharmaceuticals; research and development in the field of biotherapeutics for the treatment of genetic diseases, cancer, diabetes, obesity, metabolic syndrome, dementia, and other aging associated pathologies such as mitochondrial disease, joint strain and tears, ligament strain and tears, muscle atrophy, muscular dystrophy, neuromuscular diseases, neurological disorders, neurodegenerative disorders, inflammatory disorders, infectious diseases, genetic diseases, rare diseases, in-born errors of metabolism (IEMs), lysosomal storage disorders and urea cycle disorders; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; laboratory diagnostics; genetic engineering services; genetic research; research in the field of gene editing technology; research in the field of DNA mutation; information, advisory and consultancy services relating to the aforesaid.
Case File Event Statements
  • 11/21/2024 - 2 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 11/22/2024 - 2 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/19/2024 - a month ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/23/2024 - a month ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/22/2024 - 2 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/24/2024 - a month ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 1/22/2025 - 19 days ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 2/9/2025 - a day ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/22/2025 - 19 days ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR